Abstract
Context: Erythrocytosis is a known side effect of testosterone therapy that can increase the risk of thromboembolic events.
Objectives: To study the prevalence and determinants in the development of erythrocytosis in trans men using testosterone.
Design: A twenty-year follow-up...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.